Anticoagulants Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-27

1
Global Anticoagulants Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Anticoagulants Market Research Report
2022-2027 The latest report by IMARC Group,
titled Anticoagulants Market Global Industry
Trends, Share, Size, Growth, Opportunity, and
Forecast 2022-2027, finds that the global
anticoagulants market size reached a value of US
34.0 Billion in 2021. Anticoagulants, also
known as blood thinners, are chemical substances
that prevent or reduce the coagulation of blood
and extend the blood clotting time. They are
utilized to minimize the risk of blood clots in
various medical conditions, such as myocardial
infarction, deep vein thrombosis, pulmonary
embolism, and stroke. These drugs are usually
available in capsule or tablet form, including
warfarin, rivaroxaban, dabigatran, and apixaban.
Owing to these properties, doctors widely
prescribe anticoagulants to people who are at a
high risk of clot formation. Request for a PDF
sample of this report https//www.imarcgroup.com/
anticoagulants-market/requestsample

4
Report Description and Highlights
Report Description
Global Anticoagulants Market Trends The market
is primarily driven by the rising incidences of
hypercoagulability across the globe. According to
studies, hypercoagulability in individuals
affected by the coronavirus disease (COVID-19)
pandemic can be one of the leading causes of
mortality, which is escalating the demand for
anticoagulants. In addition, the growing
prevalence of human immunodeficiency virus (HIV),
hepatitis C, Lyme disease, obesity, cancer, and
chronic inflammation, represents another major
growth-inducing factor. Besides this, extended
sitting, smoking, trauma, blood disorders, and
autoimmune diseases can cause blood clotting in
different parts of the body. This, coupled with
the improving diagnosis rates and the rising
adoption of target therapeutics, is positively
influencing the market growth. Furthermore, the
surging number of surgeries requiring prolonged
bed rest also increases the risk of blood clots
among individuals, thus propelling the market
growth. Looking forward, IMARC Group expects
the market to reach a value of US 60.8 Billion
by 2027, exhibiting a CAGR of 10.2 during the
forecast period (2022-2027). View Report TOC,
Figures and Tables https//www.imarcgroup.com/ant
icoagulants-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Drug Class
• Novel Oral Anticoagulants (NOACs)
• Heparin and Low Molecular Weight Heparin (LMWH)
• Vitamin K Antagonist
• Others
•  
• Breakup by Route of Administration
• Oral Anticoagulant
• Injectable Anticoagulant
• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Others

6
Report Description and Highlights
Report Description

•  
• Breakup by Application
• Atrial Fibrillation and Heart Attack
• Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Alexion Pharmaceuticals Inc
• Aspen Holdings
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company Limited
• Dr. Reddys Laboratories Ltd
• GlaxoSmithKline plc
• Johnson Johnson Private Limited
• Pfizer Inc.
• Sanofi.
•  

8
Key Questions Answered in the Report
Report Description

• How has the global anticoagulants market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global anticoagulants market?
• What are the key regional markets?
• What is the breakup of the market based on the
  drug class?
• What is the breakup of the market based on the
  route of administration?
• What is the breakup of the market based on the
  distribution channel?
• What is the breakup of the market based on the
  application?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global
  anticoagulants market and who are the key
  players?
• What is the degree of competition in the
  industry?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Anticoagulants
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Drug Class    6.1  
 Novel Oral Anticoagulants (NOACs)        6.1.1
Market Trends        6.1.2 Market Forecast   
6.2    Heparin and Low Molecular Weight Heparin
(LMWH)        6.2.1 Market Trends        6.2.2
Market Forecast    6.3    Vitamin K Antagonist 
      6.3.1 Market Trends        6.3.2 Market
Forecast    6.4    Others        6.4.1 Market
Trends        6.4.2 Market Forecast 7    Market
Breakup by Route of Administration    7.1  
 Oral Anticoagulant        7.1.1 Market Trends 
      7.1.2 Market Forecast          Click here
to visit the complete table of content with list
of figures and tables https//www.imarcgroup.com/
anticoagulants-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us